Sinphar Pharmaceutical Co.,Ltd. (1734.TW) TAI

32.10

+0.15(+0.47%)

Updated at August 19 01:35PM

Currency In TWD

Valuation

Market Cap5.65B
Enterprise Value6.48B
P/E Ratio18.91
PEG Ratio31.77
Price/Sales Ratio1.82
Price/Book Ratio1.71
Enterprise/Revenue2.09
Enterprise/EBITDA10.48

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.1
Operating Margin0.1

Management Effectiveness

Return On Assets0.05
Return On Equity0.09

Income Statement

Revenue3.15B
Revenue/Share17.54
Gross Profit1.24B
EBITDA601.24M
Net Income304.71M
Diluted EPS1.68

Balance Sheet

Total Cash1.12B
Total Cash/Share6.21
Total Debt1.81B
Total Debt/Equity0.53
Current Ratio2.54
Book Value Per Share20.25

Price History

52-Week Change-5.44
52-Week High34.91
52-Week Low27.25
Moving Average 50 Days32.08
Moving Average 200 Days31.43

Statistics

Average Volume189,306
Shares Outstanding181.14M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield3.13
Payout Ratio0.55
Last Split Factor27:25
Last Split DateSeptember 04, 2024